MEDIPOST Co., Ltd. (078160.KQ)
KRW 12000.0
(-11.37%)
KRW 12000.0
(-11.37%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -25.13 Billion KRW | -46.38% |
| 2022 | -17.49 Billion KRW | -202.04% |
| 2021 | -5.79 Billion KRW | -126.29% |
| 2020 | -2.56 Billion KRW | 69.15% |
| 2019 | -8.29 Billion KRW | 7.97% |
| 2018 | -9.01 Billion KRW | -4.64% |
| 2017 | -8.61 Billion KRW | 7.52% |
| 2016 | -9.31 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -6.11 Billion KRW | 38.97% |
| 2024 Q2 | -9.91 Billion KRW | -51.32% |
| 2023 Q1 | -4.36 Billion KRW | -36.47% |
| 2023 Q2 | -5.07 Billion KRW | -16.37% |
| 2023 Q3 | -6.09 Billion KRW | -19.92% |
| 2023 Q4 | -10.02 Billion KRW | -64.57% |
| 2023 FY | -25.61 Billion KRW | -46.38% |
| 2022 Q2 | -4.7 Billion KRW | -44.65% |
| 2022 FY | -17.49 Billion KRW | -202.04% |
| 2022 Q4 | -3.19 Billion KRW | 49.08% |
| 2022 Q3 | -6.28 Billion KRW | -33.46% |
| 2022 Q1 | -3.25 Billion KRW | -51.54% |
| 2021 Q3 | -1.45 Billion KRW | 0.0% |
| 2021 FY | -5.79 Billion KRW | -126.29% |
| 2021 Q4 | -2.14 Billion KRW | -47.87% |
| 2020 FY | -2.56 Billion KRW | 69.15% |
| 2019 FY | -8.29 Billion KRW | 7.97% |
| 2018 FY | -9.01 Billion KRW | -4.64% |
| 2017 FY | -8.61 Billion KRW | 7.52% |
| 2016 FY | -9.31 Billion KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HLB Co., Ltd. | -125.02 Billion KRW | 79.899% |
| iNtRON Biotechnology, Inc. | -3.28 Billion KRW | -665.023% |
| BINEX Co., Ltd. | 1.04 Billion KRW | 2511.166% |
| Bioneer Corporation | 791.75 Million KRW | 3274.058% |
| Anterogen.Co.,Ltd. | -5.07 Billion KRW | -395.299% |
| CrystalGenomics, Inc. | -30.91 Billion KRW | 18.705% |
| Helixmith Co., Ltd | -35.24 Billion KRW | 28.698% |
| Chabiotech Co.,Ltd. | -9.42 Billion KRW | -166.633% |
| Medy-Tox Inc. | 17.32 Billion KRW | 245.077% |
| Peptron, Inc. | -15.6 Billion KRW | -61.064% |
| Amicogen, Inc. | 2.05 Billion KRW | 1322.226% |
| Genexine, Inc. | -41.24 Billion KRW | 39.064% |
| HLB Therapeutics Co.,Ltd. | -8.7 Billion KRW | -188.85% |
| LegoChem Biosciences, Inc. | -80.82 Billion KRW | 68.906% |
| ALTEOGEN Inc. | -9.73 Billion KRW | -158.099% |
| PharmaResearch Co., Ltd. | 100.81 Billion KRW | 124.927% |
| SillaJen, Inc. | -21.34 Billion KRW | -17.731% |
| JETEMA, Co., Ltd. | 2.63 Billion KRW | 1054.219% |
| OliX Pharmaceuticals,Inc | -18.18 Billion KRW | -38.192% |
| Genomictree Inc. | -17.3 Billion KRW | -45.235% |
| MedPacto, Inc. | -28.75 Billion KRW | 12.595% |
| D&D Pharmatech | -13.48 Billion KRW | -86.343% |
| EASY BIO,Inc. | 20.63 Billion KRW | 221.809% |
| GI Innovation, Inc. | -55.6 Billion KRW | 54.804% |